Oncology

The SEIV Oncology Working Group highlights the crucial role of medical technologies in the overall management of cancer, from prevention and early diagnosis to treatment, monitoring, and improving patients' quality of life.

In recent years, advancements in medical technology have significantly contributed to increased survival rates and the transition toward more personalized, effective, and safe care. Medical devices, in vitro diagnostics, and digital health solutions work complementarily, shaping an integrated oncology care ecosystem.

In prevention and early detection, new technologies such as liquid biopsies, genomic testing, and advanced screening programs enable the identification of the disease at early stages, where therapeutic interventions are more effective. In diagnosis, progress in imaging, molecular biomarker analysis, and artificial intelligence supports accurate disease classification and the selection of appropriate treatment.

In treatment, innovations such as robotic surgery, minimally invasive techniques, companion diagnostics, and therapy support technologies enhance clinical outcomes, reduce complications, and improve the patient experience. At the same time, digital solutions, from clinical decision support systems to real-world data analysis, contribute to more evidence-based and efficient interventions.

However, despite the progress, significant challenges remain: inequalities in access, delays in reimbursement and adoption of innovations, limited use of data, and insufficient recognition of the value of medical technologies across the full spectrum of oncology care.

The SEIV Oncology Working Group aims to actively contribute to shaping policies and practices that will enhance patient access to innovative technologies, promote a value-based approach to healthcare, and support a sustainable, efficient, and patient-centered oncology care system in Greece.